What is ILARIS:

ILARIS is a medicine that contains the active substance Canakinumab and is available as 80 mg powder for solution for injection.

Ilaris – Canakinumab 180 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.

In how many countries ILARIS is approved for marketing?

ILARIS is available/approved in USA and Europe. We can help you to access it in India.

What is ILARIS used for?

ILARIS is indicated for the treatment of:
• Cryopyrin-Associated Periodic Syndromes (CAPS), in adults and children 4 years of age and older including:
• Familial Cold Autoinflammatory Syndrome (FCAS)
• Muckle-Wells Syndrome (MWS)
• Active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older